Karim El Bakkouri

M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection

D. G. Eliasson, A. Omokanye, K. Schön, U. A. Wenzel, V. Bernasconi, M. Bemark, Annasaheb Kolpe, Karim El Bakkouri (UGent) , Tine Ysenbaert (UGent) , Lei Deng (UGent) , et al.

(2018) MUCOSAL IMMUNOLOGY. 11(1). p.273-289

Add to list

Hierarchical and redundant roles of activating FcγRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies

Silvie Van den Hoecke (UGent) , Katrin Ehrhardt, Annasaheb Kolpe, Karim El Bakkouri (UGent) , Lei Deng (UGent) , Hendrik Grootaert (UGent) , Steve Schoonooghe (UGent) , Anouk Smet (UGent) , Mostafa Bentahir (UGent) , Kenny Roose (UGent) , et al.

(2017) JOURNAL OF VIROLOGY. 91(7).

Add to list

Book Chapter

Cutting edge approaches towards novel and cross-protective influenza vaccines

Kenny Roose (UGent) , Michael Schotsaert (UGent) , Karim El Bakkouri (UGent) , Bert Schepens (UGent) , Walter Fiers and Xavier Saelens (UGent)

(2012) Development of novel vaccines : skills, knowledge and translational technologies. p.205-233

Add to list

The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections

Konstantin H Müller, Denis E Kainov, Karim El Bakkouri (UGent) , Xavier Saelens (UGent) , Jef K De Brabander, Christian Kittel, Elisabeth Samm and Claude P Muller

(2011) BRITISH JOURNAL OF PHARMACOLOGY. 164(2). p.344-357

Add to list

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus

Dubravka Grdic Eliasson, Anja Helgeby, Karin Schon, Caroline Nygren, Karim El Bakkouri (UGent) , Walter Fiers, Xavier Saelens (UGent) , Karin Bengtsson Lovgren, Ida Nystrom and Nils Y Lycke

(2011) VACCINE. 29(23). p.3951-3961

Academic Bibliography

Karim El Bakkouri

M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection

Hierarchical and redundant roles of activating FcγRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies

Cutting edge approaches towards novel and cross-protective influenza vaccines

The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus

Contents

Support

Contact